French agency flags up innovation support in latest four-year plan
This article was originally published in Clinica
The French healthcare products safety agency, Afssaps, has affirmed its intention to become involved in promoting clinical innovation and to formalise procedures for dealing with innovative products and techniques so as to allow patients access to new treatments as soon as possible.
You may also be interested in...
Diagnostics company Bodysphere had to retract an announcement that it had received an emergency use authorization from the US FDA for a COVID-19 serologic test. See why Bethany Hills, an attorney with law firm Morrison & Foerster, says this may be a cautionary tale for other manufacturers.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Japanese ICT giant applies novel advanced computing techniques with a US venture partner to more rapidly identify lead molecules from a huge virtual space.